Thyrotropin suppression therapy for papillary thyroid carcinoma with a huge recurred neck lymph node

Differentiated thyroid cancer (DTC) originating from thyroid tissue is affected by thyrotropin (TSH). TSH suppression therapy is usually recommended after thyroidectomy in cases of DTC. A 57-year-old woman who harbored a very huge recurred lymph node underwent TSH suppression therapy because of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Jung Bum, Kim, Dong-il, Paik, Hyun-june, Lee, Seung Joo, Jung, Chang Shin, Kang, Seok Kyung, Jung, Youn Joo, Kim, Hyun Yul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Surgical Oncology 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942732/
https://www.ncbi.nlm.nih.gov/pubmed/36945712
http://dx.doi.org/10.14216/kjco.20023
Descripción
Sumario:Differentiated thyroid cancer (DTC) originating from thyroid tissue is affected by thyrotropin (TSH). TSH suppression therapy is usually recommended after thyroidectomy in cases of DTC. A 57-year-old woman who harbored a very huge recurred lymph node underwent TSH suppression therapy because of the risk of surgical complications. After TSH suppression, the huge neck lymph node exhibited a response and decreased in size. She had been followed up for 144 months. TSH suppression therapy could be considered as an alternative treatment option in a recurred DTC patient with a high perioperative risk.

Ejemplares similares